Inhibitory effects of alpha-zearalenol on angiotensin II-induced integrin β3 mRNA via suppression of nuclear factor-κB

Biomedical and Environmental Sciences

Volumn 18, Issue 5, 2005, Pages 314-320

  Li, Su Min ^a   Wang, Xiao Ming ^a   Qiu, Jin ^a   Si, Qin ^a   Guo, Heng Yi ^a   Sun, Ren Yu ^a   Wu, Qi Xia ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

17 estradiol; Alpha zearalenol; Endothelial cell; Integrin 3; NF B

Indexed keywords

ANGIOTENSIN II; BETA3 INTEGRIN; DRUG DERIVATIVE; ESTRADIOL; ESTROGEN RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; NITRIC OXIDE; PHYTOESTROGEN; ZEARALENOL; ZERANOL;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANGIOTENSIN II; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTEGRIN BETA3; NF-KAPPA B; NITRIC OXIDE; PHYTOESTROGENS; RECEPTORS, ESTROGEN; RNA, MESSENGER; ZERANOL;

EID: 28444470896     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Farhat, M. Y., Lavigne, M. C., and Ramwell, P. W. (1996). The vascular protective effects of estrogen. FASEB J. 10, 615-624.
2. Lissin, L. and Cooke, J. (2000). Phytoestogens and Cardiovascular Health. J. Am. Coll. Cardiol. 35, 1403-1410.
3. Hulley, S., Grady, D., Bush, T., Furberg, C., Herrington, D., Riggs, B., and VittinghoffI, E. (1998). Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 280, 605-613.
4. Jimenez, M. and Mateo, R. (1997). Determination of mycotoxins produced by Fusarium isolates fromol/L banana fruits by capillary gas chromatography and high-performance liquid chromatography. J. Chromatogr. A 778, 363-372.
5. Altavilla, D., Saitta, A., Galeano, M., and Squadrito, G. (2001). Phytooestrogen α-Zearalenol Reverses Endothelial Dysfunction Induced by Oophorectomy in Rats. Lab. Invest. 81, 125-132.
6. Dai, S. L., Duan, J. H., and Lu, Y. (2002). A new phytooestrogen α-zearalanol markedly inhibits progression of atherogencsis in overiectomized cholesterol-fed rabbits. J. Mol. Cell. Cardiol. 34, A3.
7. Kleinert, H., Wallerath, T., Euchenhofer, C, Ihrig-Biedert, I., and Li, H. (1998). Oestrogens increase transcription of the human endothelial NO synthase gene: Analysis of the transcription factors involved. Hypertension 31, 582-588.
8. Hodges, Y. K., Tung, L., Yan, X. D., Graham, J. D., Horwitz, K. B., and Horwitz, L. D. (2000). Oestrogen receptors alpha and beta: Prevelance of oestrogen receptor beta mRNA in human vascular smooth muscle and transcriptional effects. Circulation 101, 1792-1798.
9. Ling, S., Deng, G., Ives, H. E., Chatterjee, K., Rubanyi, G. M., Komesaroff, P. A., and Sudhir, K. (2001). Oestrogen inhibits mechanical strain-induced mitogenesis in human vascular smooth muscle cells via down-regulation of Sp-1. Cardiovasc. Res. 50, 108-114.
10. Sukovich, D. A., Mukherjee, R., and Benfield, P. A. (1994). A novel cell-type specific mechanism for oestrogen-receptor mediated gene activation in the absence of an oestrogen-responsive element. Mol. Cell. Biol. 14, 7134-7143.
11. Barbacanne, M. A., Rami, J., Michel, J. B., Souchard, J. P., Philippe, M., Besombes, J. P., and Bayard, F. (1999). Estradiol increases rat aorta endothelium-derived relaxing factor (EDRF) activity without changes in endothelial NO synthase gene expression: Possible role of decreased endothelium-derived superoxide anion production. Cardiovasc. Res. 41, 672-681.
12. Nichols, T. C., Fischer, T. H., Deliargyris, E. N., and Baldwin, A. S. (2001). Role of nuclear factor-kappa B (NF-kappaB) in inflammation, periodontitis, and atherogenesis. Ann. Periodontol. 1, 20-29.
13. Collins, T., Read, M. A., Neish, A.S., Whitley, M.Z., Thanos, D., and Maniatis, T. (1995). Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J. 9, 899-909.
14. Baeuerle, P. A. and Henkel, T. (1994). Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12, 141-179.
15. Sumin, L., Xiaoming, W., Jin, Q., Qin, S, Hua, W., Hengyi, G., Renyu, S., and Qixia, W. (2005). Angiotensin II Stimulates Endothelial Integrin β3 Expression via Nuclear Factor-κ B Activation. Exp. Aging Res. 31(4), (in press).
16. Ghosh, S., May, M. J., and Kopp, E. B. (1998). NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260.
17. Karin, M. (1999). The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. J. Biol. Chem. 274, 27339-27342.
18. Read, M. A., Whitley, M. Z., Williams, A. J., and Collins, T. (1994). NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation. J. Exp. Med. 179, 503-512.
19. Sheppard, K. A., Rose, D. W., and Collins, T. (1999). Transcriptional activation by NF-kappaB requires multiple coactivators. Mol. Cell Biol. 19, 6367-6378.
20. Sajid, M. and Stouffer. G. (2002). The role of αvβ3 integrin in vascular healing. Thromb. Haemost. 87, 187-193.
21. Du, X. L., Sun, Y., Chen, L., Quo, H. Y., and Wu, Q. X. (1998). The effects of high glucose and high insulin on the adhension of vascular endothelial cells. Chin. J. Pathophysiol. 14, 66-68.
22. Wang, H., Shen, C. L., Si, Q., Guo, H. Y., and Wu, Q. X. (1999).The effects of angiotensin II on integrin beta 3 in vascular endothelial cells. Chin. J. Pathophysiol. 15, 200-202.
23. Shattil, S. J. (1995). Function and regulation of the β3 integrins in hemostasis and vascular biology. Thromb. Haemost. 74, 149-155.
24. Zutter, M. M., Fong, A. M., Kringman, H. R., and Santoro, S. A. (1992). Differential regulation of α2β1 and αIIbβ3 integrin genes during megakaryocytic differentiation of pluripotential K562 cells. J. Biol. Chem. 267, 20233-20236.
25. Gordon, P. B., Sussman, I. I., and Hatcher, V. B. (1983). Long-term culture of human endothelial cells. In vitro 19, 661-671.
26. Chung-Welch, N., Patton, W. F., Yen-Patton, G. P., Hechtman, H. B., and Shepro, D. (1989). Phenotypic comparison between mesothelial and microvascular endothelial cell lineages using conventional endothelial cell markers, cytoskeletal protein markers and in vitro assays of angiogenic potential. Differentiation 42, 44-53.
27. Wassmann, S., Laufs, U., Stamenkovic, D., Linz, W., and Stasch, J. P. (2002). Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production. Circulation 105, 2083-2091.
28. GI:15314714. Homo sapiens integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) (ITGB3), mRNA. Genebank.
29. GI:5016088. Homo sapiens actin, beta (ACTB), mRNA. Genebank.
30. Todd, B., Galina, S., and Peter, L. (1997). The nuclear factor kappa B signaling pathway participates in dysreglulation of vacular smooth muscle cells in vitro and in human atherosclerosis. JBC 272, 15817-15824.
31. Caulin-Glaser, T., Watson, C. A., Pardi, R., and Bender, J. R. (1996). Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J. Clin. Invest. 98, 36-42.
32. Lusis, A.J. (2000). Atherosclerosis. Nature 407, 233-241.
33. Lee, P. C., Kibbe, M. R., Schuchert, M. J., and Stolz, D. B. (2000). Nitric oxide induces angiogenesis and upregulates alpha(v)beta(3) integrin expression on endothelial cells. Microvasc. Res. 60, 269-280.
34. Speir, E., Yu, Z. X., Takeda, K., Ferrans, V. J., and Cannon, R. O. 3rd. (2000). Antioxidant effect of estrogen on cytomegalovirus-induced gene expression in coronary artery smooth muscle cells. Circulation 102, 2990-2996.
35. Dimmeler, S. and Zeiher, A. M. (2000). Reactive oxygen species and vascular cell apoptosis in response to angiotensin II and pro-atherosclerotic factors. Regul. Pept. 90, 19-25.
36. Mizutani, K., Ikeda, K., Nishikata, T., and Yamori, Y. (2000). Phytoestrogens attenuate oxidative DNA damage in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. J. Hyperten. 18, 1833-1840.
37. Dubey, R. K., Tyurina, Y. Y., Tyurin, V. A., Gillespie, D. G., Branch, R. A., Jackson, E. K., and Kagan, V. E. (1999). Oestrogen and tamoxifen metabolites protect smooth muscle cell membrane phospholipids against peroxidation and inhibit cell growth. Circ. Res. 84, 229-239.
38. Behl, C., Skutella, T., Lezoualc'h, F., Post, A., Widmann, M., Newton, C. J., and Holsboer, F. (1997). Neuroprotection against oxidative stress by oestrogens: structure-activity relationship. Mol. Pharmacol. 51, 535-541.